Last reviewed · How we verify

DNA intercalators — Competitive Intelligence Brief

DNA intercalators (DNA intercalators) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: DNA intercalator. Area: Oncology.

phase 2 DNA intercalator DNA (double helix) Oncology Small molecule Live · refreshed every 30 min

Target snapshot

DNA intercalators (DNA intercalators) — UNICANCER. DNA intercalators insert themselves between DNA base pairs to disrupt DNA replication and transcription, leading to cancer cell death.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
DNA intercalators TARGET DNA intercalators UNICANCER phase 2 DNA intercalator DNA (double helix)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (DNA intercalator class)

  1. UNICANCER · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). DNA intercalators — Competitive Intelligence Brief. https://druglandscape.com/ci/dna-intercalators. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: